Hypoglycemia was also more common in the intervention group, but there was no statistically significant difference (20% versus 10%, P-value .47) compared to the control group.[11] Adel et al found hypoglycemia in 2 among 54 participants in insulin-based treatment and in 9 of 54 of the control group; similarly, hypokalemia in 3 and 4 patients of respective groups.[22]. The gene discussed is INS; the disease is Hypokalemia.